SRXH Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-0.170.0% YoY
Profit margin0.0%CONSUMER DEFENSIVE
Market cap$106.0MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 6.44
- P/S (TTM)
- 8.29
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- -52.9%
- Revenue growth YoY
- -9.4%
- Dividend yield
- —
- Beta
- —
Last earnings
Sep 30, 2025 · Estimate $0.00 · Reported $-0.74
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About SRx Health Solutions Inc.
Company profileSRx Health Solutions Inc. provides healthcare and medical treatment services.
Classification
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Exchange
- AMEX
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 801 US HIGHWAY 1, NORTH PALM BEACH, FL
- Fiscal year end
- September
- Latest quarter
- Mar 31, 2026
Market cap$106.0M
Shares outstanding$590.3M
52W high$0.71
52W low$0.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent